Citations

Clear

5 citation(s) found for "Bollerslev, Jens".

Burden of illness in not adequately controlled chronic hypoparathyroidism: Findings from a 13‐country patient and caregiver survey
Siggelkow, Heide , Germak, John, Marelli, Claudio , Chen, Kristina , Dahl‐Hansen, Helen, Glenister, Elizabeth, Bent‐Ennakhil, Nawal , Judge, Davneet , Mycock, Katie , Bollerslev, Jens , Chen, Kristina , Clarke, B.L.

Mayo Clinic

Clinical Endocrinology | November 13, 2019 | Volume: 92 | Issue: 2 | Pages: 159-168

10.1111/cen.14128 | PMID 31721256 Get It

AbstractObjectiveTo address knowledge gaps regarding burdens associated with not adequately controlled chronic hypoparathyroidism.DesignGlobal patient and caregiver survey.Study PopulationsPatients with chronic hypoparathyroidism not adequately controlled on conventional therapy and their caregivers.MeasurementsHealth‐related quality of life (HRQoL) and health status were evaluated using the 36‐item Short Form version 2 (SF‐36 v2.0) and Five‐Level EuroQoL 5 Dimensions (EQ‐5D‐5L) instruments, respectively. Hypoparathyroidism‐associated symptoms were assessed by a disease‐specific Hypoparathyroidism Symptom Diary and caregiver burden via the Modified Caregiver Strain Index (MCSI).ResultsData were obtained from 398 patients and 207 caregivers. Patients' self‐rated hypoparathyroidism‐related symptom severity was none (3%), mild (32%), moderate (53%) or severe (12%). Per the Hypoparathyroidism Symptom Diary, patients reported moderate, severe or very severe symptoms of physical fatigue (73%), muscle cramps (55%), heaviness in limbs (55%) and tingling (51%) over a 7‐day recall period. Impacts (rated ‘somewhat’ or ‘very much’) were reported by 84% of patients for ability to exercise, 78% for sleep, 75% for ability to work and 63% for family relationships. Inverse relationships were observed between patient self‐rated overall symptom severity and HRQoL and health status assessment scores—the greater the symptom severity, the lower the SF‐36 and EQ‐5D‐5L scores. Caregiver burden increased with patient self‐rated symptom severity: none, 1.7 MCSI; mild, 5.4 MCSI; moderate, 9.5 MCSI; and severe, 12.5 MCSI.ConclusionPatients with not adequately controlled hypoparathyroidism reported substantial symptoms and impacts. Greater patient symptom severity was associated with decreased patient HRQoL and health status assessments and increased caregiver burden.
MON-520 Symptoms, Comorbidities, and Treatment Satisfaction with Chronic Hypoparathyroidism: Findings from a 13-Country Patient Survey
Bollerslev, Jens , Germak, John, Marelli, Claudio , Chen, Kristina , Dahl‐Hansen, Helen, Glenister, Elizabeth, Judge, Davneet , Gibson, Katie, Clarke, B.L. , Bent‐Ennakhil, Nawal , Gibson, Katie, Siggelkow, Heide

Mayo Clinic

Journal of the Endocrine Society | May 10, 2019 | Volume: 3 | Issue: Supplement_1 | Pages: No page available

10.1210/js.2019-mon-520 Get It

MON-519 Impact of Chronic Hypoparathyroidism on Work, Productivity, and Relationships: Findings from a 13-Country Patient and Caregiver Survey
Germak, John, Marelli, Claudio , Chen, Kristina , Dahl‐Hansen, Helen, Glenister, Elizabeth, Judge, Davneet , Gibson, Katie, Bollerslev, Jens, Clarke, B.L. , Siggelkow, Heide , Bent‐Ennakhil, Nawal , Gibson, Katie

Mayo Clinic

Journal of the Endocrine Society | May 10, 2019 | Volume: 3 | Issue: Supplement_1 | Pages: No page available

10.1210/js.2019-mon-519 Get It

MON-521 Impact of Chronic Hypoparathyroidism on Health-Related Quality of Life: Findings from a 13-Country Patient Survey
Germak, John, Marelli, Claudio , Chen, Kristina , Dahl‐Hansen, Helen, Glenister, Elizabeth, Judge, Davneet , Gibson, Katie, Bollerslev, Jens, Siggelkow, Heide , Clarke, B.L. , Bent‐Ennakhil, Nawal , Gibson, Katie

Mayo Clinic

Journal of the Endocrine Society | May 10, 2019 | Volume: 3 | Issue: Supplement_1 | Pages: No page available

10.1210/js.2019-mon-521 Get It

Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus
Khan, Aliya , Koch, Christian A. , Uum, Stan Van , Baillargeon, Jean‐Patrice , Bollerslev, Jens, Brandi, Maria Luisa , Marcocci, Claudio , Rejnmark, Lars , Rizzoli, René , Shrayyef, Muhammad , Yıldız, Bülent Okan , Clarke, Bart, Brandi, Maria Luisa , Rejnmark, Lars , Thakker, Rajesh V. , Clarke, B.L.

Mayo Clinic

European Journal of Endocrinology | December 11, 2018 | Volume: 180 | Issue: 3 | Pages: P1-P22

10.1530/eje-18-0609 | PMID 30540559 Get It

Purpose: To provide practice recommendations for the diagnosis and management of hypoparathyroidism in adults. Methods: Key questions pertaining to the diagnosis and management of hypoparathyroidism were addressed following a literature review. We searched PubMed, MEDLINE, EMBASE and Cochrane databases from January 2000 to March 2018 using keywords ‘hypoparathyroidism, diagnosis, treatment, calcium, PTH, calcidiol, calcitriol, hydrochlorothiazide and pregnancy’. Only English language papers involving humans were included. We excluded letters, reviews and editorials. The quality of evidence was evaluated based on the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. These standards of care for hypoparathyroidism have been endorsed by the Canadian Society of Endocrinology and Metabolism. Results: Hypoparathyroidism is a rare disease characterized by hypocalcemia, hyperphosphatemia and a low or inappropriately normal serum parathyroid hormone level (PTH). The majority of cases are post-surgical (75%) with nonsurgical causes accounting for the remaining 25% of cases. A careful review is required to determine the etiology of the hypoparathyroidism in individuals with nonsurgical disease. Hypoparathyroidism is associated with significant morbidity and poor quality of life. Treatment requires close monitoring as well as patient education. Conventional therapy with calcium supplements and active vitamin D analogs is effective in improving serum calcium as well as in controlling the symptoms of hypocalcemia. PTH replacement is of value in lowering the doses of calcium and active vitamin D analogs required and may be of value in lowering long-term complications of hypoparathyroidism. This manuscript addresses acute and chronic management of hypoparathyroidism in adults. Main conclusions: Hypoparathyroidism requires careful evaluation and pharmacologic intervention in order to improve serum calcium and control the symptoms of hypocalcemia. Frequent laboratory monitoring of the biochemical profile and patient education is essential to achieving optimal control of serum calcium.